L-FMAU (Clevudine)

Pharmasset to Develop Clevudine for the Treatment of Chronic Hepatitis B - 7/13/05

The Optimal Dose of Potent Experimental Anti-HBV Drug Clevudine Appears to Be >10 mg Once Daily - 11/05/04

In Dose Escalation Study, Clevudine Shows Potent Anti-HBV Effects 24 Weeks After Cessation of Once Daily Dosing 08/02/04